Trastuzumab deruxtecan
Trastuzumab deruxtecan
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-R-0905 | 1mg | 880.00 | + Add to cart |
|
R-R-0905 | 5mg | 2150.00 | + Add to cart |
|
|
Product description
Trastuzumab deruxtecan (DS-8201a)/CAS No.1826843-81-5 is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.
Appearance | N/A |
---|---|
Molecular Weight | N/A |
Purity | >90% |
CAS | 1826843-81-5 |
Synonyms | DS-8201; DS-8201a |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product